Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanta Subbarao

Showing results (131-140 of 300) with videos related to

Pageof 30
Sort By:
Med (New York, N.Y.)|September 28, 2023
Ancestral, Delta, and Omicron (BA.1) SARS-CoV-2 strains are dependent on serine proteases for entry throughout the human respiratory tractMatthew J Gartner, Leo Yi Yang Lee, Francesca L Mordant, et al.
Expert Review of Vaccines|June 2, 2022
Nonhuman primate models for evaluation of SARS-CoV-2 vaccinesJessica A Neil, Maryanne Griffith, Dale I Godfrey, et al.
Molecular Therapy. Nucleic Acids|March 20, 2026
Delivery of monoclonal antibodies using mRNA lipid nanoparticles confers protection against SARS-CoV-2 and influenzaMai N Vu, Jessica A Neil, Charley Mackenzie-Kludas, et al.
Mbio|June 1, 2017
<i>In Vivo</i> Imaging of Influenza Virus Infection in Immunized MiceRita Czakó, Leatrice Vogel, Elaine W Lamirande, et al.
Vaccine|December 3, 2014
Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccineTara M Babu, Min Levine, Theresa Fitzgerald, et al.
The Journal of Hospital Infection|May 26, 2026
Room-return ventilation and N95 respirator policies for reducing airborne pathogen exposure on hospital wardsCameron Zachreson, Xiangdong Li, Kevin Kevin, et al.
Virology|December 31, 2002
Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse geneticsKanta Subbarao, Hualan Chen, David Swayne, et al.
Viral Immunology|October 2, 2010
Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccineAnjeanette Roberts, Elaine W Lamirande, Leatrice Vogel, et al.
Clinical & Translational Immunology|May 16, 2022
Off-target effects of bacillus Calmette-Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19Nicole L Messina, Susie Germano, Rebecca McElroy, et al.
Journal of Virology|October 20, 2017
<i>In Vitro</i> Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in MiceTroy C Sutton, Elaine W Lamirande, Kevin W Bock, et al.
Pageof 30

Showing results (131-140 of 300) with videos related to

Sort By:
Pageof 30
Med (New York, N.Y.)|September 28, 2023
Ancestral, Delta, and Omicron (BA.1) SARS-CoV-2 strains are dependent on serine proteases for entry throughout the human respiratory tractMatthew J Gartner, Leo Yi Yang Lee, Francesca L Mordant, et al.
Expert Review of Vaccines|June 2, 2022
Nonhuman primate models for evaluation of SARS-CoV-2 vaccinesJessica A Neil, Maryanne Griffith, Dale I Godfrey, et al.
Molecular Therapy. Nucleic Acids|March 20, 2026
Delivery of monoclonal antibodies using mRNA lipid nanoparticles confers protection against SARS-CoV-2 and influenzaMai N Vu, Jessica A Neil, Charley Mackenzie-Kludas, et al.
Mbio|June 1, 2017
<i>In Vivo</i> Imaging of Influenza Virus Infection in Immunized MiceRita Czakó, Leatrice Vogel, Elaine W Lamirande, et al.
Vaccine|December 3, 2014
Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccineTara M Babu, Min Levine, Theresa Fitzgerald, et al.
The Journal of Hospital Infection|May 26, 2026
Room-return ventilation and N95 respirator policies for reducing airborne pathogen exposure on hospital wardsCameron Zachreson, Xiangdong Li, Kevin Kevin, et al.
Virology|December 31, 2002
Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse geneticsKanta Subbarao, Hualan Chen, David Swayne, et al.
Viral Immunology|October 2, 2010
Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccineAnjeanette Roberts, Elaine W Lamirande, Leatrice Vogel, et al.
Clinical & Translational Immunology|May 16, 2022
Off-target effects of bacillus Calmette-Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19Nicole L Messina, Susie Germano, Rebecca McElroy, et al.
Journal of Virology|October 20, 2017
<i>In Vitro</i> Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in MiceTroy C Sutton, Elaine W Lamirande, Kevin W Bock, et al.
Pageof 30